In the present study, the risks of all-cause death and MACEs were particularly increased in patients with NT-proBNP levels ≥ 411.3 pg/ml, suggesting this value as an appropriate cut-off NT-proBNP level for prediction of all-cause death and MACEs in very old patients with stage 3 CKD. Here, NPPB is linked to chronic kidney disease.